期刊文献+

厄贝沙坦治疗原发性高血压合并动脉导管未闭1例

原文传递
导出
摘要 患者,女性,44岁,因反复胸闷气促40年,发现先(天性心脏病6月,于2011-03-10收入我院心内科。患l者40年前于感冒后出现胸闷气促,伴轻度心悸,无胸:痛,无头晕、晕厥,无端坐呼吸、颜面四肢水肿,无咳嗽、咳痰、恶心、呕吐等其他不适,感冒好转后胸闷气促及轻度心悸等不适缓解,未予重视。40年间,患者反复于:感冒或劳累后出现胸闷气促感,休息后不适可好转,未曾正规诊治。6月前,患者因四肢乏力就诊于当地医;院,行心脏彩色多普勒超声检查提示先天性心脏病,动脉导管未闭,为行动脉导管未闭介入封堵术入院。
作者 金伟权
出处 《中华高血压杂志》 CAS CSCD 北大核心 2012年第5期479-480,共2页 Chinese Journal of Hypertension
  • 相关文献

参考文献6

  • 1Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the ESH/ESC [J]. J Hypertens, 2007,28(12) : 1462-1536.
  • 2Feldman RD, Zou GY, Vandervoort MK, et al. A simplified approach to the treatment of uncomplicated hypertension. A cluster randomized controlled trial [J ]. Hypertension, 2009,53 (4) : 646- 653.
  • 3孙宁玲,荆珊,陈捷.厄贝沙坦/氢氯噻嗪复方片剂治疗中国高血压病患者的达标率分析[J].中华心血管病杂志,2005,33(7):618-621. 被引量:108
  • 4Coca A, Calvo C, Sobrino J, et al. Once-daily fixed-combination irbesartan 300mg/hydrochlorothiazide 25rag and circadian blood pressure profile in patients with essential hypertension[J]. Clin Ther, 2003,25 ( 11 ) :2849-2864.
  • 5Bobrie G, Delonca J, Moulin C, et al. A home blood pressure monitoring study: comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations[J]. Am J Hypertens, 2005,18( 11 ) : 1482-1488.
  • 6Neutel JM, Smith D. Ambulatory blood pressure comparison of the anti-hypertensive efficacy of fixed combinations of irbesartan/ hydroehlorothiazide and losartan/ hydrochlorothiazide in patients with mild-to-moderate hypertension[J]. J Int Med Res, 2005,33 (6) :620-631.

二级参考文献7

  • 1Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension, 2003,42:239-246.
  • 2Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet,2000,29;356:366-372.
  • 3Howe P, Phillips P, Saini R, et al.The antihypertensive efficacy of the combination of irbesartan and hydrochlorothiazide assessed by 24-hour ambulatory blood pressure monitoring. Irbesartan Multicenter Study Group. Clin Exp Hypertens. 1999,21:1373-1396.
  • 4中国高血压防治指南起草委员会.1999中国高血压防治指南[J].高血压杂志,2000,8:94-112.
  • 5European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens,2003,21:1011-1053.
  • 6Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.Lancet. 1998,351:1755-1762.
  • 7蒋雄京,李卫,马林茂,孔灵芝,金水高,刘力生.医院门诊就诊人群高血压相关知识及其对高血压防治的影响[J].中华流行病学杂志,2002,23(4):269-272. 被引量:40

共引文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部